Vatiquinone
PTC743-NEU-003e-FA
Phase 3 small_molecule active
Quick answer
Vatiquinone for Friedreich Ataxia is a Phase 3 program (small_molecule) at PTC THERAPEUTICS, INC. with 3 ClinicalTrials.gov record(s).
Program details
- Company
- PTC THERAPEUTICS, INC.
- Indication
- Friedreich Ataxia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active